Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mid-Atlantic BioTherapeutics

Mid-Atlantic BioTherapeutics
2011 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$875K LATEST DEAL AMOUNT
Description

Owner and operator of biotechnology firm intended to eradicate infectious diseases using a novel, patented technology platform. The company's platform addresses the growing antibiotic resistance problems and creating a revolutionary treatment paradigm for viral diseases like Tamiflu alternative for influenza, emerging infectious diseases and biodefense, enabling doctors to provide effective treatment for influenza, creating a powerful alternative to Tamiflu and rabies.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • 3805 Old Easton Road
  • Doylestown, PA 18902
  • United States

+1 (215) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mid-Atlantic BioTherapeutics’s full profile, request a free trial.

Mid-Atlantic BioTherapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 05-Oct-2018 $875K 000.00 Completed Clinical Trials - Phase 1
1. Capitalization 01-Jan-2018 0000 0000 Completed Clinical Trials - Phase 1
To view this company’s complete deal history including valuation and funding, request access »

Mid-Atlantic BioTherapeutics Executive Team (2)

Name Title Board
Seat
Contact
Info
David Horn MD Co-Founder, Chief Executive Officer & Chairman
Jean-Pierre Gagnon Co-Founder, Senior Vice President & Board Member

Mid-Atlantic BioTherapeutics Board Members (4)

Name Representing Role Since Contact
Info
David Horn MD Mid-Atlantic BioTherapeutics Co-Founder, Chief Executive Officer & Chairman 000 0000
Jean-Pierre Gagnon Mid-Atlantic BioTherapeutics Co-Founder, Senior Vice President & Board Member 000 0000
Julian Chick Ph.D Mid-Atlantic BioTherapeutics Board Member 000 0000
Michael Goldblatt Ph.D Mid-Atlantic BioTherapeutics Board Member 000 0000